Semax Research Sourcing Guide — this article examines published research context, laboratory applications, and procurement notes for Semax (5mg / 10mg) in Neuropeptide Research programs at Sulan Peptide Official.
Semax is a synthetic ACTH-derived heptapeptide used in laboratory research on neuropeptide signaling, melanocortin-related pathway models, peptide stability, and cellular response studies.
Sulan Peptide organizes Semax under Neuropeptide Research for qualified buyers reviewing ACTH-derived peptide products, melanocortin-related pathway models, vial formats, and quotation details.
Available Semax formats include 5mg and 10mg options. The product page supports research-use sourcing with CAS number, molecular formula, molecular weight, purity target, appearance, storage guidance, and pricing information.
Laboratories preparing Semax protocols commonly pair the material with Sterile Bacteriostatic Water (BAC), Precision laboratory pipettes, Low-bind microtubes, Vial storage organizers (-20°C). These are workflow accessories—not bundled in the vial.
Research teams working with Semax often include Neuropeptide research labs, Melanocortin pathway researchers, Cellular response study groups, Preclinical peptide pharmacology teams, Qualified peptide procurement teams. These groups typically require documented peptide identity, batch COA review, and RUO compliance before releasing material into cell or animal protocols.
Semax is an ACTH(4-10) analog studied for neurotrophic effects involving BDNF upregulation and dopaminergic pathway modulation in stroke and hypoxia rodent models.
Heptapeptide lacks corticotropic activity of full ACTH while retaining CNS signaling properties in blood–brain barrier penetration research.
Morris water maze performance, infarct volume histology (TTC staining), and BDNF ELISA from brain homogenates are recurring experimental endpoints.
Institute of Molecular Genetics ( Moscow ) publications established Semax in cerebral ischemia research models as a neuroactive peptide probe.
Procurement workflow: Open the Semax product page under Neuropeptide Research on sulanpeptide.shop. Confirm specification (5mg / 10mg), published COA entries, and Cat No. before internal requisition. Include destination country and quantity when contacting Sulan Peptide Official via sales@sulanpeptide.shop or WhatsApp +447599352109.
When reviewing Semax, read the product overview “What is Semax?” alongside the specification table. Principal investigators often approve SKUs only after mechanism fit is documented in the study protocol.
Repeat procurement of Semax for multi-phase studies should reference prior lot numbers in reorder messages if batch continuity affects assay comparability across experiment waves.
Literature searches for Semax should use both trade names and CAS 80714-61-0 to capture mechanistic papers missed by supplier marketing keywords alone.
Pilot experiments with Semax often start at mid-range catalog specifications (5mg / 10mg) before scaling quantity for full study cohorts.
Cell viability panels should precede mechanism assays when introducing Semax to new cell lines—unexpected toxicity may reflect solvent choice rather than peptide sequence.
For long-horizon Neuropeptide Research projects, document freezer location and thaw count on every aliquot label tied to Semax lot numbers.
Appearance notes (White Lyophilized Powder) help detect moisture exposure or handling damage during receiving inspection of Semax.
Internal IRB or IACUC protocols should cite RUO scope explicitly when Semax appears in animal or human-derived tissue research models.
Compare published assay incubation times for Semax; overnight versus short pulses can invert apparent potency rankings in receptor assays.
Purity target ≥ 99.0% on the catalog is a specification goal—your QA team should confirm the specific lot COA meets internal thresholds before release.
Catalog specification data for Semax lists CAS 80714-61-0, Molecular formula C37H51N9O10S. molecular weight 813.9 g/mol, and purity target ≥ 99.0%. Match these identifiers to incoming COA documents and internal sample labels before assay use.
Supplier storage guidance for Semax: Store at -20°C, in a cool and dry place. Log receipt date, lot number, and freezer location when material enters your inventory. Plan aliquots before reconstitution to limit freeze-thaw cycles during multi-week assay series.
Available Semax research formats on sulanpeptide.shop include 5mg10vials, 10mg10vials. Cat No. references (XA5, XA11) should appear on requisitions so quoted material matches the specification selected during protocol design.
Shipping seasonality can affect lyophilized cake integrity for Semax; inspect vials after extreme transit delays even if COA predates shipment.
Training records for staff handling Semax should cover reconstitution math, RUO policy, and spill cleanup for research laboratories.
Dose–response studies with Semax typically span log-scale concentrations; your protocol should state whether dosing is by mass (5mg / 10mg) or molarity derived from molecular weight on the product page.
Published Neuropeptide Research papers often include positive and negative assay controls alongside Semax; budget control compounds before ordering experimental material.
When designing multi-arm studies, randomize vial lot assignment and blind analysts to supplier identity until primary readouts are locked—this reduces bias in vendor comparison experiments involving Semax.
When Semax appears in combination with other peptides, cite each sequence’s Cat No. in publications to satisfy reproducibility standards in Neuropeptide Research journals.
Statistical plans should pre-register primary endpoints before unblinding Semax treatment arms in preclinical models.
Semax from Sulan Peptide Official is supplied for research use only (RUO)—not for human or veterinary use, diagnosis, or treatment. Direct specification or quotation questions via the Contact page or WhatsApp on sulanpeptide.shop.